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Association of ventricular arrhythmia and
in-hospital mortality in stroke patients in Florida
A nonconcurrent prospective study
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∗
, Juan Gabriel Ruiz, MD, PhDb,
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Abstract
Stroke remains one of the leading causes of death in the United States. Current evidence identiﬁed electrocardiographic
abnormalities and cardiac arrhythmias in 50% of patients with an acute stroke. The purpose of this study was to assess whether the
presence of ventricular arrhythmia (VA) in adult patients hospitalized in Florida with acute stroke increased the risk of in-hospital
mortality.
Secondary data analysis of 215,150 patients with ischemic and hemorrhagic stroke hospitalized in the state of Florida collected by
the Florida Agency for Healthcare Administration from 2008 to 2012. The main outcome for this study was in-hospital mortality. The
main exposure of this study was deﬁned as the presence of VA. VA included the ICD-9 CM codes: paroxysmal ventricular tachycardia
(427.1), ventricular ﬁbrillation (427.41), ventricular ﬂutter (427.42), ventricular ﬁbrillation and ﬂutter (427.4), and other – includes
premature ventricular beats, contractions, or systoles (427.69). Differences in demographic and clinical characteristics and hospital
outcomes were assessed between patients who developed versus did not develop VA during hospitalization (x2 and t tests). Binary
logistic regression was used to estimate unadjusted and adjusted odds ratios and 95% conﬁdence intervals (CIs) between VA and in-
hospital mortality.
VA was associated with an increased risk of in-hospital mortality after adjusting for all covariates (odds ratio [OR]: 1.75; 95% CI:
1.6–1.2). There was an increased in-hospital mortality in women compared to men (OR: 1.1; 95% CI: 1.1–1.14), age greater than 85
years (OR: 3.9, 95% CI: 3.5–4.3), African Americans compared to Whites (OR: 1.1; 95% CI: 1.04–1.2), diagnosis of congestive heart
failure (OR: 2.1; 95% CI: 2.0–2.3), and atrial arrhythmias (OR: 2.1, 95% CI: 2.0–2.2). Patients with hemorrhagic stroke had increased
odds of in-hospital mortality (OR: 9.0; 95% CI: 8.6–9.4) compared to ischemic stroke.
Identifying VAs in stroke patients may help in better target at risk populations for closer cardiac monitoring during hospitalization.
The impact of implementing methods of quick assessment could potentially reduce VA associated sudden cardiac death.
Abbreviations: AA = atrial arrhythmias, AHCA = Agency for Health Care Administration, ANS = autonomic nervous system, CHF
= coronary heart failure, CI= conﬁdence interval, CVD= cerebrovascular disease, DM= diabetesmellitus, ECG= electrocardiogram,
HTN = hypertension, ICD = international classiﬁcation of diseases, OR = odds ratio, PVC = premature ventricular contraction, US =
United States, VA = ventricular arrhythmia.
Keywords: Florida, in-hospital mortality, stroke, ventricular arrhythmia
1. Introduction
According to the World Health Organization, 15 million people
worldwide suffer a stroke annually.[1] Of these, nearly 6 million
die and another 5 million are left permanently disabled, placing a
burden on family and community. Stroke remains one of the
leading causes of death in the United States (US) with around
129,000 events each year.[2] The highest death rates from stroke
in the US occur in the Southeast region where the state of Florida
is located. Florida has one of most diverse minority populations
in the US including African Americans and Hispanics, and in
2013 reported 8142 strokes.[3] Disparities in acute stroke
diagnosis, management, and care, along with secondary preven-
tion exist for African Americans, but are less well documented in
the rapidly growing Hispanic population.[3]
Early experimentation was conducted using rat models by
Oppenheimer et al.[4] This study showed connections between the
insula, autonomic changes, and cardiac arrhythmias. Signiﬁcant
dysrhythmias on electrocardiogram (ECG) were documented
after stimulation of the anterior cortex, similar to those observed
after an ischemic stroke. In contrast to the control group, the
majority of the experimental individuals experienced various
dysrhythmias such as p-wave alterations, progressive QRS
complex widening, and premature ventricular complexes. These
ﬁndings led to the identiﬁcation of cortical sites that control
central and peripheral cardiac autonomic changes in relation to
ventricular arrhythmia (VA) in patients after a stroke.[4] Another
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study by Koppikar et al assessed the effects after an acute stroke
particularly within the ﬁrst 24hours.[5] They showed that 14% of
patients had nonsustained ventricular tachycardia while 36%
presented ventricular ectopic beats.
Serious cardiac events are common in the acute period after
stroke. Early observations identiﬁed electrocardiographic
(ECG) abnormalities and cardiac arrhythmias in 50% of
patients with an acute stroke.[6] Patients at highest risk are
identiﬁable and may beneﬁt from more aggressive strategies to
improve survival.[7] There is ample research with regard to
atrial arrhythmias (AA) as an independent risk factor for stroke
but few studies have explored the association of VAs and
cerebrovascular disease (CVD). One of the most serious cardiac
consequences after a stroke is an increased risk of VA,which can
increase the risk of sudden death.[8,9] The proposed mechanism
by which VA may occur following stroke involves autonomic
imbalance modulated by direct injury to neurogenic structures
and enhanced by catecholamine surge leading to myocardial
damage and arrhythmogenesis.[10] Experimental and clinical
data have also suggested that strokes involving the insular
cortex play a direct role in autonomic dysregulation and the
development of VA in the acute period following stroke.
However, very few studies have been performed that speciﬁcally
look at in-hospital mortality of stroke patients with VAs,
particularly in the state of Florida which has a very diverse
patient demographic.
The main aim of this study was to assess whether the presence
of VA in stroke patients increase the risk of in-hospital mortality
in Florida from 2008 to 2012.
2. Methods
A secondary analysis of data collected from 2008 to 2012 as part
of the Florida Agency for Health Care Administration (AHCA)
registry was conducted using a nonconcurrent, population-
based, cohort design.
The database comprised information from 319,492 adult
patients with the diagnosis of acute stroke from all hospitals
within the state of Florida. Stroke was deﬁned according to
following international classiﬁcation of diseases (ICD)-9 codes:
cerebrovascular accident ischemic (434.91), cerebrovascular
accident embolic (434.11), intracerebral hemorrhage (431),
other or unspeciﬁed intracerebral hemorrhage (432.9), occlusion
of cerebral arteries (434), occlusion and stenosis of the
precerebral arteries (433), acute but ill-deﬁned CVD (436),
and other generalized ischemic CVD (437.1).
Children, deﬁned as under the age of 18, and patients having
the diagnosis of transient ischemic attack (ICD-9 Code), acute ill-
deﬁned CVD, late CVD effects, other ill-deﬁned CVD,
subarachnoid hemorrhage (SAH), transient cerebral ischemia,
and unspeciﬁed intracranial hemorrhage as the primary diagnosis
were excluded from the study.
Themain outcome for this study was in-hospital mortality. The
main exposure of this study was deﬁned as the presence of VA.
VA included the ICD-9 CM codes: paroxysmal ventricular
tachycardia (427.1), ventricular ﬁbrillation (427.41), ventricular
ﬂutter (427.42), ventricular ﬁbrillation and ﬂutter (427.4), and
other – includes premature ventricular beats, contractions, or
systoles (427.69). The presence of ventricular dysrhythmias was
ascertained for this study if reported by the hospital to the AHCA
registry during the current admission. Potential confounders
included gender, age, race, ethnicity, principal payer, and type of
stroke, coronary artery disease (CAD), hypertension (HTN), AA,
congestive heart failure (CHF), diabetes mellitus (DM), tobacco
use, and obesity. Gender was divided into 2 groups: male and
female. Age was divided into 5 groups: 18 to 54, 55 to 64, 65 to
74, 75 to 84, and 85+ years-of-age. Race was divided into 3
groups: White, Black, and other (native American, Alaska native,
Asian, Paciﬁc Islander, Native Hawaiian, Other, and Unknown).
Ethnicity was divided into 2 groups: Hispanic andNon-Hispanic.
Principal payer or insurance type was divided into 5 groups:
Medicare, Medicaid, other government (TriCare or Other
Federal Government, VA, other state/local government), pri-
vate/other (which included Commercial Health Insurance,
Worker’s Compensation, other, and commercial liability cover-
age), and no insurance (which included self-pay and nonpay-
ment). Type of stroke was divided into 2 groups: ischemic and
hemorrhagic. Both ischemic and hemorrhagic strokes were effect
modiﬁers and additional stratiﬁcation was completed. CAD,
HTN, AA (atrial ﬁbrillation and atrial ﬂutter), CHF, DM,
tobacco use, and obesity were divided into groups denoting the
presence or absence of the respective comorbidity. The effect
modiﬁer was the type of stroke (ischemic or hemorrhagic) as
deﬁned by the database.
2.1. Statistical analysis
IBM Statistical Package for the Social Sciences v21 was used to
conduct all analyses. Exploratory analysis was carried out by
examining frequency distribution. Chi-square test was used to
test bivariate associations between potential confounders and the
exposures and outcome, respectively. Binary logistic regression
was used to estimate unadjusted and adjusted odds ratios (ORs)
and 95% conﬁdence intervals (CIs) between VA and in-hospital
mortality. A P-value of less than 0.05 was considered statistically
signiﬁcant.
2.2. Ethical considerations
Ethical approval was waived since the analysis was considered
nonhuman subjects research by the Florida International
University Health Science Institutional Review Board.
3. Results
The total number of patients in the database was 333,367, but
854 people were younger than 18 years and an additional
117,363 records in the registry corresponded to transient
ischemic attack, acute ill-deﬁned CVD, late CVD effects, other
ill-deﬁned CVD, subarachnoid hemorrhage (SAH), transient
cerebral ischemia, and unspeciﬁed intracranial hemorrhage
leaving an eligible population of 215,150 patients who were
included in the analysis. Overall in-hospital mortality was 5%
and overall frequency of VAs was 2%.
Table 1 shows the baseline characteristics of Florida stroke
patients according to presence of VA during 2008 and 2012.
Patients with VA tended to be male, older (>75 years old), black,
insured byMedicare, obese, and tended to have CAD, CHF, DM,
and AA (P-values< .05). The patients who did not have VA
tended to be tobacco users and hypertensive. No statistically
signiﬁcant difference in type of stroke or ethnicity was observed
between patients with and without VA.
Table 2 shows the unadjusted and adjusted association of in-
hospital mortality among Florida stroke patients (2008–2012).
The baseline characteristics of stroke patients according to in-
hospital mortality showed a signiﬁcantly higher proportion of
Dahlin et al. Medicine (2017) 96:28 Medicine
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death in patients with VA than patients without VA. All potential
confounders were signiﬁcantly associated with in-hospital
mortality. The unadjusted and adjusted OR for the association
between VA and in-hospital mortality showed patients with VA
had almost twice the odds of in-hospital mortality compared to
patients without VA (OR: 1.89, 95% CI: 1.69–2.10). After
adjustment, there was a 1.75 (95%CI: 1.56–1.97) higher odds of
in-hospital mortality for patients with VA compared to patients
without VA, while holding all other variables constant. In the
adjusted model, females had a 10% increased odds of in-hospital
mortality comparedwith men. As age increased the adjusted odds
of in-hospital mortality increased. African Americans had a 10%
increased adjusted odds of in-hospital mortality compared to the
reference group (White) while the “Other race” category had no
signiﬁcant difference in odds of in-hospital mortality. Hispanics
had a 10% increased odds of in-hospital mortality compared to
the non-Hispanic patient group. Patients with CAD were not
signiﬁcantly different than patients without CAD in terms of in-
hospital mortality. CHF increased odds of in-hospital mortality
by 2.12 (95%CI: 1.97–2.28). Patients with a hemorrhagic stroke
had 9 times greater odds of in-hospital mortality compared to
patients with an ischemic stroke.
Table 3 shows the adjusted association of type of stroke and in-
hospital mortality among Florida stroke patients (2008–2012).
After stratifying by type of stroke we found that ischemic stroke
patients with VA have a 74% increased odds of in-hospital
mortality compared to those without VA. Hemorrhagic stroke
patients with VA had a 31% higher odds of in-hospital mortality
compared to those without VA.
4. Discussion
Our study showed that there was a 75% increased odds of in-
hospital mortality in stroke patients who had VAwhen compared
to patients without VA after controlling for various factors.
There are 2 main pathophysiological mechanisms that
may explain ventricular arrhythmogenesis following strokes.
The ﬁrst hypothesis suggests that there may be damage to the
central structures that have direct control over the autonomic
nervous system (ANS).[11] This damage results in sympathetic
ampliﬁcation or parasympathetic inhibition of the ANS, with
subsequent ECG changes, without permanent myocardial
damage. The 2nd hypothesis proposes an imbalance between
sympathetic and parasympathetic reﬂex controls, leading to an
augmented sympathetic discharge.[12] These changes have been
noted to occur slowly unlike the 1st mechanism, they can cause
myocytolysis that creates the setting for VA observed after
stroke.
Table 1
Baseline characteristics of Florida stroke patients according to presence of ventricular arrhythmia during 2008 and 2012.
Ventricular arrhythmia
No Yes Total
n, % n, % n, % P
(n=208,826) (n=4395) (n=213,221)
Sex <.001
Male 106,054 (50.8) 2778 (63.2) 108,832
Female 102,772 (49.2) 1617 (36.8) 104,389
Age group, y <.001
<55 24,947 (11.9) 362 (8.2) 25,309
55–64 35,205 (16.9) 629 (14.3) 35,834
65–74 52,108 (25.0) 1070 (24.3) 53,178
75–84 60,271 (28.9) 1456 (33.1) 61,727
85+ 36,295 (17.4) 878 (20.0) 37,173
Race <.001
White 164,729 (79.5) 3405 (78.0) 168,134
Black 32,970 (15.9) 802 (18.4) 33,772
Other 9581 (4.6) 160 (3.7) 9741
Ethnicity .398
Hispanic 53,259 (26.0) 1099 (25.5) 54,358
Non-Hispanic 151,364 (74.0) 3218 (74.5) 154,582
Insurance <.001
Medicare 148,312 (71.0) 3365 (76.6) 151,677
Medicaid 13,233 (6.3) 284 (6.5) 13,517
Other gov/VA 4329 (2.1) 70 (1.6) 4339
No insurance 12,685 (6.1) 191 (4.3) 12,876
Private 30,236 (14.5) 554 (12.6) 30,790
Type of stroke .505
Ischemic 188,407 (90.2) 3952 (89.9) 192,359
Hemorrhagic 20,419 (9.8) 443 (10.1) 20,862
Coronary artery disease 66,032 (31.6) 2018 (45.9) 68,050 <.001
Congestive heart failure 88,298 (42.3) 3212 (73.1) 91,510 <.001
Hypertension 146,390 (70.1) 2855 (65.0) 149,215 <.001
Atrial arrhythmias 42,400 (20.3) 1532 (34.9) 43,932 <.001
Diabetes mellitus 72,664 (34.8) 1648 (37.5) 74,312 <.001
Tobacco use 33,589 (16.1) 647 (14.7) 34,236 <.001
Obesity 18,951 (9.1) 487 (11.1) 19,438 <.001
VA= ventricular arrhythmia.
Dahlin et al. Medicine (2017) 96:28 www.md-journal.com
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Several case studies using animal models have shown theremay
be an anatomical link in the brain that is associated with
development of VA. There is evidence to suggest that the limbic
system, speciﬁcally the amygdala and insular cortex, may be
involved in central control of the ANS.[13] Strokes involving the
right insula decrease basal sympathetic tone and may result in
parasympathetic hyperactivity. Insular lesions are usually part of
a larger infarct supplied by the middle cerebral artery. Due to this,
most studies on humans have not isolated insular infarcts to
determine the impact of lateralization on autonomic function.
Thus, it is possible that infarcts in this location may be
contributing to the increased incidence of VA (2%) in our
population.
After initial data analysis we realized that type of stroke could
be an effect modiﬁer, so we decided to stratify by type of stroke
and observed there was a difference in in-hospital mortality
between patients with VA and hemorrhagic stroke versus
ischemic stroke and saw that type of stroke was an effect
modiﬁer. After stratifying by type of stroke we found that
ischemic stroke patients with VA had higher odds of in-hospital
mortality compared to those without VA. Hemorrhagic stroke
patients with VA had a higher risk of in-hospital mortality
compared to those without VA. We contribute this pattern to the
more malignant nature of hemorrhagic strokes. It is plausible that
hemorrhagic stroke patients were underreported in the database
due to these patients expiring prior to reaching the hospital.
Similarly, depending on stroke severity, hemorrhagic stroke
patients may be less likely to be diagnosed with VA prior to
succumbing to their disease. Finally, in the VAs group, the
presence of a higher frequency of ischemic heart disease, heart
failure, and AA may be partially explained by alterations in
central sympathetic regulation expressed as a chronically elevated
sympathetic nerve activity.[14,15]
Our ﬁndings are in line with previous studies and conﬁrms the
malignant sequelae of VA in stroke patients and supports the
notion that development of VA in stroke patients infers increased
mortality. Patients with hemorrhagic stroke had 9 times greater
odds of in-hospital mortality compared to patients with an
ischemic stroke. It has been reported in the literature that
anywhere from 10% to 20% of all strokes are hemorrhagic
whereas the ischemic subtype accounts for 80% to 90%. In our
study, hemorrhagic stroke accounted for 10% of all events. A
Danish study compared hemorrhagic versus ischemic stroke on
the basis of stroke severity, mortality, and cardiovascular risk
Table 3
Adjusted association of type of stroke and in-hospital mortality
among Florida stroke patients from 2008 to 2012.
Type of stoke
Hemorrhagic Ischemic
Adjusted Adjusted
OR
∗
(95% CI†) OR (95% CI)
Ventricular arrhythmia 1.31 (1.05–1.63) 1.76 (1.54–2.01)
Sex
Male Ref‡ Ref
Female 1.10 (1.03–1.18) 1.07 (1.01–1.13)
Age group, y
<55 Ref Ref
55–64 1.07 (0.95–1.21) 1.08 (0.95–1.23)
65–74 1.29 (1.12–1.49) 2.22 (1.94–2.54)
75–84 1.48 (1.29–1.71) 3.01 (2.63–3.44)
85+ 1.28 (1.10–1.49) 4.12 (3.59–4.73)
Race
White Ref Ref
Black 0.96 (0.87–1.05) 1.25 (1.15–1.36)
Other 0.80 (0.67–0.96) 1.11 (0.96–1.28)
Ethnicity
Non-Hispanic Ref Ref
Hispanic 0.95 (0.88–1.03) 1.19 (1.12–1.27)
Insurance
Private Ref Ref
Medicare 0.79 (0.70–0.89) 0.28 (0.26–0.31)
Medicaid 1.06 (0.91–1.22) 0.81 (0.71–0.92)
Other gov/VA 1.58 (1.29–1.94) 2.11 (1.83–2.43)
No insurance 1.12 (0.97–1.30) 0.88 (0.76–1.02)
Coronary artery disease 1.08 (0.99–1.17) 0.88 (0.83–0.93)
Congestive heart failure 0.76 (0.71–0.81) 2.41 (2.26–2.56)
Hypertension 0.81 (0.75–0.87) 0.68 (0.64–0.72)
Atrial arrhythmias 1.34 (1.23–1.46) 2.13 (2.01–2.27)
Diabetes mellitus 0.98 (0.91–1.06) 0.89 (0.83–0.94)
Tobacco use 0.78 (0.69–0.88) 0.65 (0.59–0.72)
Obesity 0.77 (0.67–0.89) 0.74 (0.66–0.82)
CI=conﬁdence interval, OR= odds ratio, VA= ventricular arrhythmia.
∗
Odds ratio.
† Conﬁdence interval.
‡ Reference group.
Table 2
Unadjusted and adjusted association of in-hospital mortality
among Florida stroke patients (2008–2012).
Unadjusted Adjusted
OR
∗
(95% CI†) OR (95% CI)
Ventricular arrhythmia 1.89 (1.69–2.10) 1.75 (1.56–1.97)
Sex
Male Ref‡ Ref
Female 1.12 (1.10–1.19) 1.09 (1.05–1.14)
Age group, y
<55 Ref Ref
55–64 0.86 (0.80–93) 1.10 (1.01–1.20)
65–74 0.82 (0.80–0.88) 2.05 (1.86–2.25)
75–84 1.21 (1.13–1.30) 2.94 (2.68–3.23)
85+ 1.69 (1.57–1.81) 3.88 (3.52–4.28)
Race
White Ref Ref
Black 1.07 (1.01–1.13) 1.11 (1.04–1.18)
Other 1.14 (1.04–1.25) 1.00 (0.90–1.12)
Ethnicity
Hispanic Ref Ref
Non-Hispanic 0.84 (0.88–1.06) 1.09 (1.03–1.14)
Insurance
Private Ref Ref
Medicare 0.78 (0.74–0.82) 0.41 (0.38–0.44)
Medicaid 0.97 (0.88–1.06) 0.91 (0.82–1.00)
Other gov/VA 2.26 (2.04–2.51) 1.98 (1.76–2.23)
No insurance 0.85 (0.77–0.93) 1.01 (0.91–1.12)
Type of stroke
Ischemic Ref Ref
Hemorrhagic 9.07 (8.70–9.46) 8.96 (8.57–9.37)
Coronary artery disease 0.90 (0.86–0.94) 0.97 (0.92–1.01)
Congestive heart failure 1.79 (1.72–1.86) 2.12 (1.97–2.28)
Hypertension 0.72 (0.69–0.75) 0.70 (0.67–0.74)
Atrial arrhythmias 1.33 (1.29–1.39) 2.13 (2.04–2.22)
Diabetes mellitus 0.81 (0.77–0.84) 0.92 (0.88–0.96)
Tobacco use 1.33 (1.28–1.39) 0.8 (0.7–0.8)
Obesity 0.69 (0.64–0.75) 0.75 (0.69–0.82)
CI= conﬁdence interval, OR=odds ratio, VA= ventricular arrhythmia.
∗
Odds ratio.
† Conﬁdence interval.
‡ Reference group.
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factors.[16] Their results were in line with our reporting that the
hemorrhagic subtype comprised 10% of all strokes. They
concluded that strokes are generally more severe in patients
with hemorrhagic stroke and that hemorrhagic stroke was
associated with a considerable increase in mortality. Our study
did not exclusively look at factors favoring ischemic versus
hemorrhagic strokes but more attention should be given in the
future to this topic as well as risk stratiﬁcation and identifying
risk factors for VA after a stroke. If we can identify certain risk
factors that predispose to VA after stroke, clinicians can
incorporate preventative measures.
The observed overall in-hospital mortality of 5% is relatively
low in comparison with other studies such as the aforementioned
study from Denmark where they reported a 49% overall
mortality for hemorrhagic stroke and 26% overall mortality
for ischemic stroke; however, their study included follow-up data
whereas our study was limited to in-hospital events.[14] Our 5%
overall in-hospital mortality rate more closely reﬂects the 7-day
unadjusted case fatality rates for ischemic (1.8%) and hemor-
rhagic stroke (13.2%) reported by Graham et al.[14] This
highlights an area of potential future research in which stroke
patients with VA receive extensive follow-up. In addition, it is
important to mention that while ventricular tachycardia,
ﬁbrillation, and ﬂutter certainly carry high risks of cardiovascular
death, premature ventricular contractions (PVCs) are less likely
to confer direct patient in-hospital mortality. In our study, 0.8%
(n=1788) of the patients had PVCs (ICD-9 codes 427.60,
427.61, 427.69); however, there was no signiﬁcant association
between PVCs and mortality (P= .107).
In our study, we found a 2% overall prevalence of VA. Our
overall frequency of VA in stroke patients is lower than reported
by some previous studies. Koppikar et al[5] reported electrocar-
diographic abnormalities and cardiac arrhythmias in up to 50%
of patients with an acute stroke. This discrepancy in frequency
could be accounted for by ourmore selective deﬁnition of VA.We
only included paroxysmal ventricular tachycardia, ventricular
ﬁbrillation, ventricular tachycardia, premature ventricular beats,
contractions, and systoles, whereas other studies were more
liberal in their deﬁnition of arrhythmia and included AA and
diagnoses such as long QT syndrome and torsades de pointe. Few
if any previous studies have exclusively studied overall frequency
of VA in stroke patients. Moreover, the increasing progression of
CVD as a whole may also explain the differences in age groups.
The strengths of this study include the generalizability of the
population-based study design that included all patients
hospitalized with stroke during the study years from a well-
characterized Floridian population.
The limitation of this study includes the lack of case validation.
The Florida AHCA requests hospital reports based on the ICD-9
discharge diagnosis, which are not necessarily validated by a
neurologist or by imaging studies under a standardized criteria.
We did not have information on the severity of the stroke or the
availability of a stroke team. In addition, because we could not
determine whether in-hospital treatment approaches were
prescribed either before or after the acute stroke, we did not
adjust for receipt of in-hospital medications in the multivariate-
adjusted regression models. Finally, we did not examine the roles
of other risk factors for stroke, such as cigarette smoking, or
control for HTN and diabetes.
In conclusion, future research should utilize a prospective
cohort design to better elicit causality. Nevertheless, 2% of all
stroke patients developing deadly VA is alarming and precau-
tionary measures should aim to promote prevention, early
detection and management with emphasis on continuous cardiac
monitoring, drug therapy, and/or electrolyte correction as guided
by the clinical scenario. The impact of implementing methods of
quick assessment could potentially reduce VA associated sudden
cardiac death.
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